Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma is a research paper published in Translational Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: MCB-1715019
National Institutes of Health
Grant: P30CA023074
National Institutes of Health
Grant: P30ES006694
NCI NIH HHS
Grant: T32 CA211036
National Institutes of Health
Grant: T32CA009213
National Science Foundation
Grant: MCB-1122088
National Institutes of Health
Grant: 5P30ES006694-23
Southwest Environmental Health Sciences Center
National Science Foundation
Grant: 1122088
Lysine Deacetylases as Coactivators in Glucocorticoid Receptor Signaling
National Science Foundation
Grant: 1715019
The Role of Lysine Deacetylases in Regulating Transcriptional Dynamics at Glucocorticoid-activated Genes
National Institutes of Health
Grant: 2P30CA023074-41
University of Arizona Cancer Center - Cancer Center Support Grant
National Institutes of Health
Grant: 5T32CA009213-27
CANCER BIOLOGY TRAINING GRANT
Hope Foundation
FWCI
0.74
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords